# MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

> **NCT02674347** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 21 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** 3 g or 6 g Zidebactam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02674347
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674347, "MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02674347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*